Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
Мақола

Evaluation of the prevalence of HPV from environmentally unfavorable districts of the Republic of Karakalpakistan.

N. ZakhirovaRepublican Specialized Scientific-Practical Medical Center of Oncology and Radiology, Tashkent, UzbekistanMirzagaleb TillyashaykhovRepublican Specialized Scientific-Practical Medical Center of Oncology and Radiology, Tashkent, UzbekistanD. NishanovRepublican Specialized Scientific-Practical Medical Center of Oncology and Radiology, Tashkent, UzbekistanViloyat SaydakhmedovaRepublican Specialized Scientific-Practical Medical Center of Oncology and Radiology, Tashkent, UzbekistanElnara OsmanovaRepublican Specialized Scientific-Practical Medical Center of Oncology and Radiology, Tashkent, UzbekistanKhurshid IslamovRepublican Specialized Scientific-Practical Medical Center of Oncology and Radiology, Tashkent, Uzbekistan
ABI

Аннотация

e17526 Background: Identification of HPV-positive women in the Aral regions of the Republic of Karakalpakstan and the city of Chirchik, Tashkent region. Methods: The study included 48,788 women aged 30-55 years.The project was approved by the Ministry of Health of the Republic, covering 10 districts, mainly near the Aral Sea: Khojeyli, Kanlykul, Shumanay, Chimbay, Karauzyak, Kungrad, Kegeili, Muynak, Buzatau, Nukus district. The Xpert HPV Assay is a qualitative in vitro diagnostic test for the detection of the E6/E7 region of high oncogenic risk human papillomavirus (HPV) genomic DNA in patient specimens. The analysis was performed on a Cepheid Gene Xpert system. The Xpert HPV test specifically identified HPV 16 and HPV 18/45 types in two separate detection channels and reported the presence of 11 other high risk virus types (31, 33, 35, 39, 51, 52, 56, 58, 59, 66 and 68) as a combined result. Results: Of these, HPV was detected in 3304 (6.8%) women, HPV-negative women were 45.484 (93.2%). Distribution by HPV types: among HPV-positive women HPV 16 - 28%; HPV 18.45-7.6%; HPV 31.33.35.52-23.9%; HPV 51-11.6%; HPV 39.56.66-18.4%; mixed forms - 10.2%. Erroneous tests were 2.9%. The age of HPV positive women was 35-45 years. Conclusions: In the studied regions, HPV types 16,31,33,35,52 were most often detected, which should be taken into account when developing the country's national screening program. Also, given the age-specific prevalence of HPV, may be considered for the target group of cervical cancer screening of women aged 35 and 45 years, which is more acceptable for a developing country.

Ҳали таржима қилинмаган

Мавзулар

Идентификаторлар

Иқтибослар ва манбалар

0 та иқтибос0 та фойдаланилган манба
Кўрсаткичлар — AkademScholar · Тез орада